{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:00:33Z","timestamp":1783472433254,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.medmal.2008.11.013","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T04:47:20Z","timestamp":1232772440000},"page":"234-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Vaccination antiamarile\u00a0: mise au point \u00e0 propos des effets ind\u00e9sirables rares et graves"],"prefix":"10.1016","volume":"39","author":[{"given":"M.-C.","family":"Receveur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bruyand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Malvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2008.11.013_bib1","first-page":"349","article-title":"Yellow fever vaccine. WHO position pape","volume":"78","author":"Anonymous","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.medmal.2008.11.013_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow fever: a decade of reemergence","volume":"276","author":"Robertson","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2008.11.013_bib3","unstructured":"Rodhain F. Le myst\u00e8re des \u00e9pid\u00e9mies. 2005\u00a0: Paris, \u00c9ditions Pasteur."},{"key":"10.1016\/j.medmal.2008.11.013_bib4","first-page":"50","article-title":"Progress in the control of yellow fever in Africa","volume":"80","author":"Anonymous","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.medmal.2008.11.013_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.medmal.2005.06.009","article-title":"Les pathog\u00e8nes \u00e9mergents, la veille internationale et le r\u00e8glement sanitaire international (2005)","volume":"36","author":"Formenty","year":"2006","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.medmal.2008.11.013_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2004.05.018","article-title":"Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast","volume":"23","author":"Fitzner","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib7","first-page":"305","article-title":"Detection and management of the yellow fever epidemic in the Ivory Coast","volume":"62","author":"Akoua-Koffi","year":"2002","journal-title":"Med Trop"},{"key":"10.1016\/j.medmal.2008.11.013_bib8","first-page":"317","article-title":"Yellow fever situation in Africa and South America, 2005","volume":"81","author":"Anonymous","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.medmal.2008.11.013_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.vaccine.2005.08.077","article-title":"Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons, Liberia, 2004","volume":"24","author":"Huhn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/511869","article-title":"Yellow fever: epidemiology and prevention","volume":"44","author":"Barnett","year":"2007","journal-title":"CID"},{"key":"10.1016\/j.medmal.2008.11.013_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2008.11.013_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcv.2004.12.001","article-title":"Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium","volume":"33","author":"Bae","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.medmal.2008.11.013_bib13","doi-asserted-by":"crossref","unstructured":"Fatal yellow fever in a traveller returning from Amazonas, Brazil, 2002. JAMA 2002;287:2499\u20132500.","DOI":"10.1001\/jama.287.19.2499"},{"key":"10.1016\/j.medmal.2008.11.013_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213","volume":"35","author":"Dos Santos","year":"1995","journal-title":"Virus Res"},{"key":"10.1016\/j.medmal.2008.11.013_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.medmal.2008.11.013_bib16","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.medmal.2008.11.013_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.medmal.2008.11.013_bib18","unstructured":"Stamaril. http:\/\/www.aventis-pasteur-msd.fr\/datavax\/produits\/stamaril.htm (site consult\u00e9 en mars 2006)."},{"key":"10.1016\/j.medmal.2008.11.013_bib19","unstructured":"Contr\u00f4le de l\u2019immunit\u00e9 antiamarile, http:\/\/www.pasteur-cerba.com\/index.htm (site consult\u00e9 en mars 2006)."},{"key":"10.1016\/j.medmal.2008.11.013_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.idc.2004.11.004","article-title":"Yellow fever and Japanese encephalitis vaccines: indications and complications","volume":"19","author":"Marfin","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medmal.2008.11.013_bib24","unstructured":"Bae H-G, Domingo Carrasco C, Tenorio A, Teuwen D, Niedrig M. Analysis of adverse events after yellow fever vaccine 17D (abstract). Annual Meeting of the Gesellschaft f\u00fcr Virologie, M\u00fcnchen, Germany, 2006."},{"key":"10.1016\/j.medmal.2008.11.013_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0140-6736(01)05374-0","article-title":"Rarity of adverse effects after 17D yellow-fever vaccination","volume":"358","author":"Marianneau","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib26","first-page":"1","article-title":"Yellow Fever Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.medmal.2008.11.013_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and molecular analyses of yellow fever 17DD vaccine virus associated with serious adverse events in Brazil","volume":"290","author":"Galler","year":"2001","journal-title":"Virololgy"},{"key":"10.1016\/j.medmal.2008.11.013_bib28","doi-asserted-by":"crossref","unstructured":"Barrett ADT, Monath TP, Barban V, Niedrig M, Teuwen DE. 17D yellow fever Vaccines: new insights, a report of a workshop held during the World Congress on Medicine and Health in the Tropics, Marseille, France, Monday 12 September 2005. Vaccine 2007;25:2758\u201365.","DOI":"10.1016\/j.vaccine.2006.12.015"},{"key":"10.1016\/j.medmal.2008.11.013_bib29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3201\/eid1009.040197","article-title":"Genetic divergence and dispersal of yellow fever virus","volume":"10","author":"Vasconcelos","year":"2004","journal-title":"Braz Emerg Infect Dis"},{"key":"10.1016\/j.medmal.2008.11.013_bib30","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib31","unstructured":"Legros F, Leroy JP, Nasst N, Saluzzo JF, de Gentile L, Teuwen D. Fi\u00e8vre jaune, \u00e9pid\u00e9miologie et pr\u00e9vention vaccinale du voyageur. Bull. Epidemiol. Hebdo 2007;236\u2013238:25\u201326"},{"key":"10.1016\/j.medmal.2008.11.013_bib32","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.33321\/cdi.2004.28.24","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.medmal.2008.11.013_bib34","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick Eidex","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.vaccine.2003.11.002","article-title":"Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil","volume":"22","author":"Filippis de","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain: case report","volume":"36","author":"Doblas","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.medmal.2008.11.013_bib37","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination. United States, 2001\u20132002","volume":"51","author":"Anonymous","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.medmal.2008.11.013_bib38","series-title":"Yellow fever","first-page":"1095","author":"Monath","year":"2004"},{"key":"10.1016\/j.medmal.2008.11.013_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.1966.03110190153047","article-title":"Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child","volume":"198","author":"Anonymous","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2008.11.013_bib40","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.medmal.2008.11.013_bib41","doi-asserted-by":"crossref","unstructured":"Jennings AD, C Gibson CA, Miller BR, Mathews JH, Mitchell CJ, Roehrig JT, et al. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis 1994;169:512-8.","DOI":"10.1093\/infdis\/169.3.512"},{"key":"10.1016\/j.medmal.2008.11.013_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.medmal.2008.11.013_bib43","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year retrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib44","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, Arilvax","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.medmal.2008.11.013_bib45","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(01)06916-1","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Troillet","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib46","unstructured":"Nguyen N, Cargnino P, Rodor F, Galland MC, Prost N, Canioni D. Safety of travelers\u2019 vaccines: a case of rhabdomyolysis after yellow fever and typhoid vaccines. Abstract p. 35. VIe Congr\u00e8s annuel de la Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie, 23e Journ\u00e9es de pharmacovigilance, Joint meeting with pharmacological societies of Brazil and Portugal, April 2002."},{"key":"10.1016\/j.medmal.2008.11.013_bib47","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(01)06914-8","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Adhiyaman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.medmal.2008.11.013_bib49","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(01)06917-3","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Werfel","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2008.11.013_bib50","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease; case report","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"key":"10.1016\/j.medmal.2008.11.013_bib51","first-page":"936","article-title":"Adverse effects of attenuated yellow fever vaccine with multiple organ injury - a case report","volume":"85","author":"Zhou","year":"2005","journal-title":"Chin Med J"},{"key":"10.1016\/j.medmal.2008.11.013_bib52","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz J, Villella A, Domingo C, Nicolas JM, de Ory F, Corachan M et al. Yellow fever-associated viscerotropic disease in Barcelano, Spain. J Trav Medicine 2008;15:202\u20135.","DOI":"10.1111\/j.1708-8305.2008.00209.x"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X08004290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X08004290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:05:58Z","timestamp":1759971958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X08004290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0399077X08004290"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2008.11.013","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination antiamarile\u00a0: mise au point \u00e0 propos des effets ind\u00e9sirables rares et graves","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2008.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}